Remarkably, activation of EGFR not only promotes tumor cell escape from immune surveillance, but it also inhibits the activity of cytotoxic T lymphocytes (CTLs) through different mechanisms such as the increased lactate excretion, the activation of T regs and the decrease of MHC I and II expression [30]. Here, EGFR is linked to neoplasm.